Envestnet Asset Management’s Krystal Biotech KRYS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.08M | Buy |
15,116
+2,717
| +22% | +$373K | ﹤0.01% | 2802 |
|
|
2025
Q1 | $2.24M | Buy |
12,399
+769
| +7% | +$139K | ﹤0.01% | 2660 |
|
|
2024
Q4 | $1.82M | Buy |
11,630
+121
| +1% | +$19K | ﹤0.01% | 2754 |
|
|
2024
Q3 | $2.09M | Buy |
11,509
+4,501
| +64% | +$819K | ﹤0.01% | 2623 |
|
|
2024
Q2 | $1.29M | Buy |
7,008
+2,535
| +57% | +$466K | ﹤0.01% | 2868 |
|
|
2024
Q1 | $796K | Buy |
4,473
+1,841
| +70% | +$328K | ﹤0.01% | 3173 |
|
|
2023
Q4 | $327K | Sell |
2,632
-1,006
| -28% | -$125K | ﹤0.01% | 3564 |
|
|
2023
Q3 | $422K | Buy |
+3,638
| New | +$422K | ﹤0.01% | 3337 |
|